ArticleCurrent cancer drug targets2015

Procyanidin B2 3,3″-di-O-gallate inhibits endothelial cells growth and motility by targeting VEGFR2 and integrin signaling pathways.

Rahul Kumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.